Page last updated: 2024-08-22

camptothecin and Cystitis

camptothecin has been researched along with Cystitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bilusic, M; Chau, CH; Cordes, LM; Dahut, WL; Figg, WD; Gulley, JL; Huitema, ADR; Karzai, F; Madan, RA; Peer, CJ; Schellens, JHM; Schmidt, KT; Wroblewski, S1
de Vries, EG; Dumez, H; Gietema, JA; Groen, HJ; Maring, JG; Porro, M; van Oosterom, AT; Wachters, FM1
Cohen, MH; Creaven, PJ; Hansen, HH; Muggia, FM; Selawry, OS1

Trials

2 trial(s) available for camptothecin and Cystitis

ArticleYear
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide.
    The oncologist, 2022, 09-02, Volume: 27, Issue:9

    Topics: Camptothecin; Cyclodextrins; Cystitis; Humans; Male; Nanoparticles; Nitriles; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome

2022
A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours.
    British journal of cancer, 2004, Jun-14, Volume: 90, Issue:12

    Topics: Adult; Antineoplastic Agents, Phytogenic; Camptothecin; Cystitis; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Polyvinyls

2004

Other Studies

1 other study(ies) available for camptothecin and Cystitis

ArticleYear
Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.
    Cancer chemotherapy reports, 1972, Volume: 56, Issue:4

    Topics: Camptothecin; Cystitis; Humans; Leukocyte Count; Leukopenia; Neoplasms; Thrombocytopenia

1972